Defining prostate cancer risk before prostate biopsy

被引：21
|
作者：
Pal, Raj P. [1 ]
Maitra, Neil U. [1 ]
Mellon, J. Kilian [1 ]
Khan, Masood A. [1 ]
机构：
[1] Univ Hosp Leicester NHS Trust, Leicester Gen Hosp, Dept Urol, Leicester LE5 4PW, Leics, England
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2013年 / 31卷 / 08期
关键词：
Prostate cancer; Biopsy; Urine; Serum; Imaging; DIGITAL RECTAL EXAMINATION; MOLECULAR URINE ASSAY; COENZYME-A RACEMASE; TMPRSS2-ERG FUSION TRANSCRIPTS; ACID-PHOSPHATASE-ACTIVITY; METHYLACYL-COA RACEMASE; GLANDULAR KALLIKREIN 2; LONG-TERM PREDICTION; RADICAL PROSTATECTOMY; ANTIGEN PSA;
D O I：
10.1016/j.urolonc.2012.05.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Prostate cancer is the most commonly diagnosed cancer in men. At present, patients are selected for prostate biopsy on the basis of age, serum prostate specific antigen (PSA), and prostatic digital rectal examination (DRE) findings. However, due to limitations in the use of PSA and DRE, many patients undergo unnecessary prostate biopsy. A further problem arises as many patients are diagnosed and treated for indolent disease. This review of the literature highlights the strengths and weaknesses of existing methods of prebiopsy risk stratification and evaluates promising serum, urine, and radiologic prostate cancer biomarkers, which may improve risk stratification for prostate biopsy in the future. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：1408 / 1418
页数：11
相关论文
共 50 条
  • [21] Prostate Cancer Detection: The Value of Performing an MRI before a Biopsy
    Shimizu, T.
    Nishie, A.
    Ro, T.
    Tajima, T.
    Yamaguchi, A.
    Kono, S.
    Honda, H.
    ACTA RADIOLOGICA, 2009, 50 (09) : 1080 - 1088
  • [22] Defining and predicting indolent and low risk prostate cancer
    Bangma, Chris H.
    Roobol, Monique J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 83 (02) : 235 - 241
  • [23] The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
    Falagario, Ugo Giovanni
    Sanguedolce, Francesca
    Cormio, Angelo
    Ninivaggi, Antonella
    Finati, Marco
    Guzzi, Francesco
    Busetto, Gian Maria
    Bettocchi, Carlo
    Castellani, Daniele
    Carrieri, Giuseppe
    Cormio, Luigi
    DIAGNOSTICS, 2025, 15 (02)
  • [24] Multiparametric MRI for detection of prostate cancer before repeated biopsy
    Boesen, Lars
    Norgaard, Nis
    Chabanova, Elizaveta
    Logager, Vibeke
    Balslev, Ingegerd
    Mikines, Kari
    Thomsen, Henrik S.
    SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 : 39 - 40
  • [25] Exercise and Prostate Cancer Risk in a Cohort of Veterans Undergoing Prostate Needle Biopsy
    Antonelli, Jodi A.
    Jones, Lee W.
    Banez, Lionel L.
    Thomas, Jean-Alfred
    Anderson, Kelly
    Taylor, Loretta A.
    Gerber, Leah
    Anderson, Tiffany
    Hoyo, Catherine
    Grant, Delores
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2009, 182 (05): : 2226 - 2231
  • [26] The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy
    Schmid, Marianne
    Hansen, Jens
    Rink, Micheal
    Fisch, Margit
    Chun, Felix
    BIOMARKERS IN MEDICINE, 2013, 7 (06) : 843 - 850
  • [27] MRI AND BIOPSY AGREEMENT IN DEFINING PROSTATE CANCER LOCATION: A MULTICENTER STUDY
    Oderda, Marco
    Albisinni, Simone
    Benamran, Daniel
    Calleris, Giorgio
    Ciccariello, Mauro
    Dematteis, Alessandro
    Diamand, Romain
    Descotes, Jean-Luc
    Fiard, Gaelle
    Forte, Valerio
    Giacobbe, Alessandro
    Marquis, Alessandro
    Marra, Giancarlo
    Messas, Aurel
    Muto, Giovanni
    Peltier, Alexandre
    Rius, Leire
    Simone, Giuseppe
    Roumeguere, Thierry
    Gontero, Paolo
    JOURNAL OF UROLOGY, 2021, 206 : E855 - E855
  • [28] Association between Hormonal Evaluation Before Prostate Needle Biopsy and Locally Advanced Prostate Cancer
    Celik, Serdar
    Bozkurt, Ozan
    Yildiz, Huseyin Alperen
    Demir, Omer
    Tuna, Burcin
    Yorukoglu, Kutsal
    Aslan, Guven
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2016, 15 (02): : 52 - 56
  • [29] The Neutrophil-to-Lymphocyte Ratio before Repeat Prostate Needle Biopsy for Predicting Prostate Cancer
    Maeda, Yoko
    Kawahara, Takashi
    Kumano, Yohei
    Ohtaka, Mari
    Kondo, Takuya
    Mochizuki, Taku
    Hattori, Yusuke
    Teranishi, Jun-Ichi
    Miyoshi, Yasuhide
    Yumura, Yasushi
    Miyamoto, Hiroshi
    Yao, Masahiro
    Uemura, Hiroji
    UROLOGIA INTERNATIONALIS, 2016, 96 (01) : 123 - 124
  • [30] The Accuracy of Two Different Calculators which Calculate the Probability of Prostate Cancer Before Prostate Biopsy
    Tuygun, Can
    Demirel, Fuat
    Imamoglu, Abdurrahim
    Yalcinkaya, Fatih
    Sertcelik, Nurettin
    Yigitbasi, Orhan
    Bakirtas, Hasan
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2009, 19 (02): : 75 - 81
12345